ELOVL2 and neoplasm: Particularly in PCa, ELOVL2 demonstrates a unique tumor-suppressive function, where its high expression is associated with favorable clinical outcomes, while its knockdown enhances malignant phenotypes including proliferation, migration, and invasion in PCa cells (Hu et al., 2022).